ObsEva
ClosedObsEva was founded in 2012, is headquartered in Geneva, Switzerland, lists 11–50 employees, and has $111.0M in recorded funding across 3 rounds.
- Headquarters
- Geneva
- Employees
- 11–50
- Founded
- 2012
- Business Model
- B2B
- Total Funding
- $111.0M
- Last Round
- $20.0M Venture RoundSep 2020
- Rounds
- 3
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds for this company. The full record is or through the API.
About
Founded in 2012 and headquartered in Geneva, Switzerland, ObsEva SA (formerly Nasdaq: OBSV) was a biopharmaceutical company focused on developing and commercializing novel therapies for conditions in women's reproductive health and pregnancy. The company's pipeline included linzagolix (GnRH receptor antagonist for uterine fibroids and endometriosis) and ebopiprant (for preterm labor). ObsEva completed an IPO in 2018. Due to financial difficulties, the company undertook a strategic reorganization in 2023 and ultimately wound down operations and laid off all employees in February 2024.
Summary
ObsEva is a Biotech company based in Geneva, Switzerland, founded in 2012. It lists 11–50 employees. It has raised $111.0M in total across 3 rounds, most recently a $20.0M Venture Round in Sep 2020.
Funding & Exit History
Sep 2020
Sign up to see all 4 events
Funding: Series A through Venture Round. Amounts, valuations, and investors where available.
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/obseva"><img src="https://indexed.vc/api/badge/company/obseva" alt="ObsEva on Indexed.vc" width="260" height="76" /></a>